Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,213 total articles

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date May 15, 2026

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date May 15, 2026

Nasdaq released its mid-month short interest positions data as of May 15, 2026, showing an increase in the number of shares sold short on the Nasdaq Global Market and the Nasdaq Capital Market. The overall short interest across all Nasdaq securities rose slightly in shares but average daily volume in days only marginally changed, indicating stable …

nCino Reports First Quarter Fiscal Year 2027 Financial Results

nCino Reports First Quarter Fiscal Year 2027 Financial Results

nCino, Inc., a platform for agentic AI banking, announced its financial results for Q1 fiscal 2027. The company reported total revenues of $159.4M, up 11% year-over-year, driven by a 12% increase in subscription revenues. GAAP operating margin improved significantly by 14 percentage points to 13%, and non-GAAP operating margin reached 28%, up 11 pe…

Zentalis Strengthens Commercial Leadership with Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as SVP of Commercial Strategy

Zentalis Strengthens Commercial Leadership with Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as SVP of Commercial Strategy

Zentalis Pharmaceuticals strengthens its commercial leadership with the appointments of Shannon Campbell to the Board of Directors and Sarah Kelly as Senior Vice President of Commercial Strategy. These hires aim to build strategic and operational capabilities to support the anticipated commercialization of azenosertib, a first-in-class WEE1 inhibit…

Sana Biotechnology to Present at June 2026 Investor Conferences

Sana Biotechnology to Present at June 2026 Investor Conferences

Sana Biotechnology, a US-based biotech company focusing on engineered cell therapies, will present business updates and a company overview at the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference in June 2026. These presentations will be webcasted and available for replay on the company's investor rel…

Ligand to Participate in June Investor Conferences

Ligand to Participate in June Investor Conferences

Ligand Pharmaceuticals announced its participation in the Stifel 2026 Boston Cross Sector 1x1 Conference and the Goldman Sachs 47th Annual Global Healthcare Conference in June 2026. The company highlighted its role as a royalty aggregator with a diversified portfolio of biopharmaceutical royalties and proprietary technologies supporting drug develo…

Frequency Electronics Inc. Announces New Contracts and Fiscal Year End Backlog that Exceeded $100 Million

Frequency Electronics Inc. Announces New Contracts and Fiscal Year End Backlog that Exceeded $100 Million

Frequency Electronics, Inc. (NASDAQ: FEIM), a leader in precision timing and frequency control products, announced new contracts totaling approximately $16 million primarily for oscillators and timing systems supporting U.S. Government space and terrestrial programs. Notably, the company has entered the emerging space defense market with a contract…

Capital Southwest Announces Quarterly Regular Dividend for the Quarter Ending September 30, 2026 and Quarterly Supplemental Dividend Payable on September 30, 2026

Capital Southwest Announces Quarterly Regular Dividend for the Quarter Ending September 30, 2026 and Quarterly Supplemental Dividend Payable on September 30, 2026

Capital Southwest Corporation, a Nasdaq-listed business development company, declared a quarterly regular dividend of $0.58 per share and a supplemental dividend of $0.06 per share for the quarter ending September 30, 2026. Dividends will be paid monthly for the regular dividend and as a lump sum for the supplemental dividend, with an option for di…

Nutanix Reports Third Quarter Fiscal 2026 Financial Results

Nutanix Reports Third Quarter Fiscal 2026 Financial Results

Nutanix, Inc. announced its Q3 fiscal 2026 financial results showing 15% year-over-year ARR growth to $2.43 billion and a 10% increase in revenue to $703.1 million. The company exceeded guidance metrics and raised its full-year outlook. Highlights include the launch of Nutanix Agentic AI, strategic partnerships including with NetApp, bare-metal Kub…

Prospect Capital Announces Sale of Valley Electric to MYR Group for Expected Gross Proceeds of $328 Million, Achieving a 4.8x Multiple of Invested Capital to Prospect Over Investment Lifetime

Prospect Capital Announces Sale of Valley Electric to MYR Group for Expected Gross Proceeds of $328 Million, Achieving a 4.8x Multiple of Invested Capital to Prospect Over Investment Lifetime

Prospect Capital Corporation announced the sale of its portfolio company, Valley Electric, to MYR Group for approximately $328 million. This transaction marks a successful exit, yielding a 20.4% annualized IRR and a 4.8x multiple on invested capital since Prospect's initial investment in 2012. Valley Electric, a key provider of electrical solutions…

MannKind to Present at Jefferies Global Healthcare Conference

MannKind to Present at Jefferies Global Healthcare Conference

MannKind Corporation announced that CEO Michael Castagna will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference. The presentation will be webcast live and recorded versions will be available online. MannKind is focused on developing innovative treatments for chronic diseases, including diabetes and pulmonary conditio…

Cytokinetics to Participate in June Investor Conferences

Cytokinetics to Participate in June Investor Conferences

Cytokinetics, a specialty cardiovascular biopharmaceutical company, announced its management team's participation in major June investor conferences including Jefferies and Goldman Sachs. The company highlighted progress in its drug pipeline, notably the approved MYQORZO® (aficamten) for obstructive hypertrophic cardiomyopathy, and upcoming present…

Townsquare to Participate in Upcoming Investor Conference

Townsquare to Participate in Upcoming Investor Conference

Townsquare Media, Inc. (NYSE: TSQ) announced that its management team will present at Noble Capital Markets' Emerging Growth Virtual Equity Conference on June 3, 2026. The presentation will include a fireside Q&A session and opportunities for 1x1 meetings with qualified investors. The event aims to increase investor engagement and provide updates o…

Safe Bulkers, Inc. Publishes Prospectus Relating to the Admission to Trading and Listing on Euronext Athens

Safe Bulkers, Inc. Publishes Prospectus Relating to the Admission to Trading and Listing on Euronext Athens

Safe Bulkers, Inc., an international marine drybulk transportation provider primarily listed on the NYSE under the ticker SB, announced the approval of its prospectus for the admission of all issued common shares to trading on the Main Market of Euronext Athens. The company will commence trading on Euronext Athens on June 2, 2026, under the ticker …